Christine Lydon

Clinical, Pathologic, and Biologic Features Associated with <i>BRAF</i> Mutations in Non–Small Cell Lung Cancer

Stephanie Cardarella, Atsuko Ogino, Mizuki Nishino et al. · Clinical Cancer Research · 2013 · 371 citations · Full text

Medicine, Genetics, Oncology +17

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

Katherine Hastings, Helena A. Yu, Wen Wei et al. · Annals of Oncology · 2019 · 370 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Five-Year Survival in EGFR -Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs

Stephanie Cardarella, Christine Lydon, Suzanne E. Dahlberg et al. · Journal of Thoracic Oncology · 2015 · 362 citations · Full text

Medicine, Oncology, Pharmacology +12

Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses

Israel Cañadas, Rohit Thummalapalli, Jong Wook Kim et al. · Nature Medicine · 2018 · 317 citations · Full text

Life Sciences, Immunology, Oncology +14

Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer

Antonio Calles, Xiaoyun Liao, Lynette M. Sholl et al. · Journal of Thoracic Oncology · 2015 · 290 citations · Full text

Medicine, Immunology, Oncology +17